Carotid artery atherosclerosis: effect of intensive lipid therapy on the vasa vasorum--evaluation by using dynamic contrast-enhanced MR imaging. - Wikidata - awgldk - TriplyDB

Carotid artery atherosclerosis: effect of intensive lipid therapy on the vasa vasorum--evaluation by using dynamic contrast-enhanced MR imaging.

Carotid artery atherosclerosis: effect of intensive lipid therapy on the vasa vasorum--evaluation by using dynamic contrast-enhanced MR imaging.

http://www.wikidata.org/entity/Q35062096

about

Dynamic Contrast-Enhanced MRI to Study Atherosclerotic Plaque Microvasculature Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaque Atherosclerosis and atheroma plaque rupture: imaging modalities in the visualization of vasa vasorum and atherosclerotic plaques Inflammation and neovascularization intertwined in atherosclerosis: imaging of structural and molecular imaging targets.Carotid plaque hemodynamics Imaging atherosclerosis in rheumatoid arthritis: evidence for increased prevalence, altered phenotype and a link between systemic and localised plaque inflammation.Three-dimensional dynamic contrast enhanced imaging of the carotid artery with direct arterial input function measurement.MRI of carotid atherosclerosis.The effect of two novel amino acid-coated magnetic nanoparticles on survival in vascular endothelial cells, bone marrow stromal cells, and macrophages Scan-rescan reproducibility of quantitative assessment of inflammatory carotid atherosclerotic plaque using dynamic contrast-enhanced 3T CMR in a multi-center study.Utilizing imaging tools in lipidology: examining the potential of MRI for monitoring cholesterol therapy.Sonographic characteristics of carotid artery plaques: Implications for follow-up planning?Imaging the efficacy of anti-inflammatory liposomes in a rabbit model of atherosclerosis by non-invasive imaging.Quantifying Intracranial Plaque Permeability with Dynamic Contrast-Enhanced MRI: A Pilot Study.Registration of dynamic contrast-enhanced MRI of the common carotid artery using a fixed-frame template-based squared-difference method.Advances in noninvasive imaging for evaluating clinical risk and guiding therapy in carotid atherosclerosis.Evaluating efficacy of pharmaceutical interventions in atherosclerosis: role of magnetic resonance imaging and positron emission tomography.Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis.Coronary cardiac allograft vasculopathy versus native atherosclerosis: difficulties in classification.Large coverage black-bright blood interleaved imaging sequence (LaBBI) for 3D dynamic contrast-enhanced MRI of vessel wall.Three-dimensional dynamic contrast-enhanced MRI for the accurate, extensive quantification of microvascular permeability in atherosclerotic plaques.Atherosclerotic plaque inflammation quantification using dynamic contrast-enhanced (DCE) MRI.How does lipid lowering prevent coronary events? New insights from human imaging trials.T1 gadolinium enhancement of intracranial atherosclerotic plaques associated with symptomatic ischemic presentations.Intraplaque hemorrhage in cardiac allograft vasculopathy.Evaluation of carotid plaque vulnerability in vivo: Correlation between dynamic contrast-enhanced MRI and MRI-modified AHA classification.Vitamin D and Vulnerable Carotid Plaque.Epicardial adipose tissue volume increase in hemodialysis patients treated with sevelamer or calcium-based phosphate binders: a substudy of the Renagel in new dialysis trial.Phase-based vascular input function: Improved quantitative DCE-MRI of atherosclerotic plaques.Increased Vascular Permeability Measured With an Albumin-Binding Magnetic Resonance Contrast Agent Is a Surrogate Marker of Rupture-Prone Atherosclerotic Plaque.Plaque Thrombosis is Reduced by Attenuating Plaque Inflammation with Pioglitazone and is Evaluated by Fluorodeoxyglucose Positron Emission Tomography.Progression of experimental lesions of atherosclerosis: assessment by kinetic modeling of black-blood dynamic contrast-enhanced MRI.Homologous HOmologous Black-Bright-blood and flexible Interleaved imaging sequence (HOBBI) for dynamic contrast-enhanced MRI of the vessel wall.Carotid vulnerable plaques are associated with circulating leukocytes in acute ischemic stroke patients: an clinical study based on contrast-enhanced ultrasound.

P2860

Q26749689-259E34C9-5783-45B4-8094-4CF18573F7DA Q26824883-24A08B17-5B37-410F-A500-C39675813D60 Q26827203-981BA8CE-1212-468D-9DCD-2389DCFA577F Q27692593-E04BC021-3DF5-4E3A-B1D7-561B720DD239 Q30847514-E0002866-EAB4-4E16-B09E-F2BC776C8088 Q33678290-DC4C694F-4D65-41E1-9F24-C89D51445540 Q33800926-B85A8DC3-6AF1-431C-8776-7FD709AAE31C Q33922492-B0EB0F66-6641-42EE-ABA0-2019292801FE Q34256625-59EA5650-71CD-437D-BC30-60EE5BBD0DD2 Q34544570-1442C5AD-DFCD-41EB-AF42-2B893AF27E7E Q36422755-36DA198B-8B68-4574-B4E8-B1B33F5DB0E2 Q36591040-2912BB07-C40E-44FC-840D-2EE577F8597B Q36728733-DB2BEF73-75B2-49D1-BCEE-3A5C2A1B6FF2 Q37641970-CCA55EFF-2239-4615-A2C0-8237F6831B68 Q37720649-C82F8E11-E42F-4816-A05F-8D8191D30016 Q37965656-3D606A96-F56B-4A0B-A706-BBE6D58CE74D Q38067325-8BA3B823-0A08-4413-BFE1-18835522C9A8 Q38094125-37E1B69C-9AC0-4E7F-A00D-5D1848D311C5 Q38210159-28A49F09-05E9-49AD-A8E5-44E9B4EF6969 Q38719914-C27B628A-0066-4DAC-8063-A0098BA31ED6 Q41839877-F676DC72-C5A0-41D4-8C36-87F7F3B01FDC Q41854592-7FA698FD-7333-49FE-97E9-9F9DCFB6C9E9 Q43162246-28BD75B2-D1F0-41B6-867A-7EC28579250B Q45831236-113E7C32-2DF6-49E0-8640-5789A60DE89D Q46034641-0C6A23A3-0AF8-42BA-BA4E-C3B991094234 Q47818885-9E54C9C8-6C3E-4299-AA72-722BC1448806 Q48196368-038C2895-5AB5-484E-ABAA-F7984EA46CE6 Q50857969-74A6BCD8-FC20-41C8-94C5-1B7924689A72 Q50872729-6D5FFEC4-3FB6-47EB-B7C9-C36CC85711F5 Q51017688-22A1CF61-0A1B-4162-B08B-81047238B19F Q53018280-6A772E13-40B5-4059-AE41-D3D828433DB2 Q53150326-619A9B4F-BC23-4C23-AE4B-77D7BB93C94C Q53556906-FF162EF9-9855-4F1D-8457-C1DB4467BB70 Q55361032-E61A8EF5-0BBB-4E31-B1E4-A4CCD53ED00B

P2860

Carotid artery atherosclerosis: effect of intensive lipid therapy on the vasa vasorum--evaluation by using dynamic contrast-enhanced MR imaging.

http://www.wikidata.org/entity/Q35062096

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Carotid artery atherosclerosis ...... contrast-enhanced MR imaging.

@ast

Carotid artery atherosclerosis ...... contrast-enhanced MR imaging.

@en

type

label

Carotid artery atherosclerosis ...... contrast-enhanced MR imaging.

@ast

Carotid artery atherosclerosis ...... contrast-enhanced MR imaging.

@en

prefLabel

Carotid artery atherosclerosis ...... contrast-enhanced MR imaging.

@ast

Carotid artery atherosclerosis ...... contrast-enhanced MR imaging.

@en

P1433

Q35062096-9E06EC6F-DEC8-468B-9D77-9E44B96AD74E

P1476

Q35062096-6F10B889-35AB-43BC-B94B-D74488DD4BE1

P2093

Q35062096-5BD2C49B-8A11-493B-B30E-1568E9293EFA

Q35062096-65CB09E5-3F2E-42D3-A0A8-F512969D97DF

Q35062096-89C412DB-B287-48DC-BCC1-389A2CA2EE0E

Q35062096-AF2320F6-9105-4875-B766-F315DEB71F2C

Q35062096-C1131682-007B-49EC-913C-9B037EC4D217

Q35062096-C187B390-9876-492A-8126-8BDFB10505B2

Q35062096-CBD65B61-1F3A-4F54-9D6E-1F658A102AF1

Q35062096-D6441DC2-79F5-49F9-A5B2-F22B4B976A3B

P2860

Q35062096-12721C10-F04F-4AE4-90E4-C16FF260FA1E

Q35062096-1B42DDFD-FB4E-4B61-9FA9-D678057FDB3B

Q35062096-1DAEF7FE-46B8-4017-B129-D26115FBE4EF

Q35062096-1DFADA40-1EE3-4881-9CFB-D353D16B06AD

Q35062096-2607D93B-A1AB-47CF-90C4-6C8D573D0D72

Q35062096-26609EE6-8132-4DCC-9BF9-A547BAE8E9CA

Q35062096-3A1586AF-953F-47DA-AFCE-8337DE008538

Q35062096-3B60CA83-80B7-46AB-BD61-99F83D45610C

Q35062096-44A33F44-5B0B-4A7B-9A35-9557571EB785

Q35062096-49ED820F-8714-4D47-BFE8-89A77720CD42

P304

Q35062096-B416248C-5EA8-4F50-9048-EE07432CEA63

P31

Q35062096-F2FE70F4-F40B-49A5-AB95-73DEEF564CFB

P356

Q35062096-5313D672-0D8F-42EB-816C-CC56D2766EBB

P407

Q35062096-BC85E8CC-CA9D-4D1D-A94E-5CC4CC619F76

P433

Q35062096-38E8AE10-DC7F-4D89-875A-F60E2E112BE4

P478

Q35062096-2CBC7A28-9825-4767-A37F-CBB17F2B256E

P50

Q35062096-D80663FD-ED57-401F-A6E8-D6AA4A4913F7

P577

Q35062096-35E1C979-AFFB-41A4-AB8E-3FC00BF40F1F

P5875

Q35062096-18643CDA-3C8E-4A15-9262-23A8F7870451

P698

Q35062096-A32D1F21-B3FF-4A75-A778-9A1A67B93482

P921

Q35062096-87FFE8EC-A53C-4B37-80BB-51C67571DDC7

P932

Q35062096-7BA12C1F-F02E-4176-8097-087D84F5FBEF

P356

RADIOL.11101264

P1433

P1476

Carotid artery atherosclerosis ...... contrast-enhanced MR imaging.

@en

P2093

Baocheng Chu

http://www.w3.org/2001/XMLSchema#string

Chun Yuan

http://www.w3.org/2001/XMLSchema#string

Hunter R Underhill

http://www.w3.org/2001/XMLSchema#string

Li Dong

http://www.w3.org/2001/XMLSchema#string

Moni Blazej Neradilek

http://www.w3.org/2001/XMLSchema#string

Thomas S Hatsukami

http://www.w3.org/2001/XMLSchema#string

Williams S Kerwin

http://www.w3.org/2001/XMLSchema#string

Xue-Qiao Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

Inflammation and atherosclerosis

Quantification of plaque neovascularization using contrast ultrasound: a histologic validation

Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging.

Neovascularization in human atherosclerosis.

Mechanism of action of niacin.

Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis

Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study.

P304

224-231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1148/RADIOL.11101264

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

260

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51051939

http://www.w3.org/2001/XMLSchema#string

P698

21493792

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

3121009

http://www.w3.org/2001/XMLSchema#string